关注
Mauro Silvestrini
Mauro Silvestrini
Professore di Neurologia, Università Politecnica delle Marche
在 univpm.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.
TS Group
New England Journal of Medicine 362 (5), 402-415, 2010
28242010
10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial
Lancet 376 (9746), 1074-1084, 2010
10942010
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source
NE Investigators
New England Journal of Medicine 378 (23), 2191-2201, 2018
9772018
Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis
M Silvestrini, F Vernieri, P Pasqualetti, M Matteis, F Passarelli, E Troisi, ...
Jama 283 (16), 2122-2127, 2000
7452000
Effect of collateral blood flow and cerebral vasomotor reactivity on the outcome of carotid artery occlusion
F Vernieri, P Pasqualetti, M Matteis, F Passarelli, E Troisi, PM Rossini, ...
Stroke 32 (7), 1552-1558, 2001
4302001
Outcome of carotid artery occlusion is predicted by cerebrovascular reactivity
F Vernieri, P Pasqualetti, F Passarelli, PM Rossini, M Silvestrini
Stroke 30 (3), 593-598, 1999
3571999
Cerebrovascular reactivity and cognitive decline in patients with Alzheimer disease
M Silvestrini, P Pasqualetti, R Baruffaldi, M Bartolini, Y Handouk, ...
Stroke 37 (4), 1010-1015, 2006
3352006
Incidence and predictors of acute symptomatic seizures after stroke
E Group
Neurology 77 (20), 1785-1793, 2011
3232011
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study.
TS Group
Lancet Neurology 10 (6), 520-529, 2011
2962011
Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial.
PS Investigators
Lancet 2011;377:2013-22 377 (9782), 2013-2022, 2011
283*2011
Hemodilution in acute stroke: results of the Italian Hemodilution Trial
IASS Group
The Lancet 331 (8581), 318-321, 1988
239*1988
Neutrophil-to-lymphocyte ratio predicts the outcome of acute intracerebral hemorrhage
S Lattanzi, C Cagnetti, L Provinciali, M Silvestrini
Stroke 47 (6), 1654-1657, 2016
2372016
Carotid artery wall thickness in patients with obstructive sleep apnea syndrome
M Silvestrini, B Rizzato, F Placidi, R Baruffaldi, A Bianconi, M Diomedi
Stroke 33 (7), 1782-1785, 2002
2372002
Efficacy and safety of cannabidiol in epilepsy: a systematic review and meta-analysis
S Lattanzi, F Brigo, E Trinka, G Zaccara, C Cagnetti, C Del Giovane, ...
Drugs 78, 1791-1804, 2018
2202018
Sex‐hormone‐related events in migrainous females. A clinical comparative study between migraine with aura and migraine without aura
LM Cupini, M Matteis, E Troisi, P Calabresi, G Bernardi, M Silvestrini
Cephalalgia 15 (2), 140-144, 1995
2201995
Topiramate in the treatment of chronic migraine
M Silvestrini, M Bartolini, M Coccia, R Baruffaldi, R Taffi, L Provinciali
Cephalalgia 23 (8), 820-824, 2003
2162003
Cerebral hemodynamic changes in sleep apnea syndrome and effect of continuous positive airway pressure treatment
M Diomedi, F Placidi, LM Cupini, G Bernardi, M Silvestrini
Neurology 51 (4), 1051-1056, 1998
2071998
Neutrophil-to-lymphocyte ratio in acute cerebral hemorrhage: a system review
S Lattanzi, F Brigo, E Trinka, C Cagnetti, M Di Napoli, M Silvestrini
Translational stroke research 10, 137-145, 2019
1982019
Age and sex differences in cerebral hemodynamics: a transcranial Doppler study
M Matteis, E Troisi, BC Monaldo, C Caltagirone, M Silvestrini
Stroke 29 (5), 963-967, 1998
1881998
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial
SE Kasner, B Swaminathan, P Lavados, M Sharma, K Muir, R Veltkamp, ...
The Lancet Neurology 17 (12), 1053-1060, 2018
1872018
系统目前无法执行此操作,请稍后再试。
文章 1–20